Hematology
The role of hematology at Penn Medicine
Hematology is the study of blood and its diseases. Some of these conditions are malignant (cancerous), while others are benign (noncancerous). Even benign blood disorders can cause serious complications without the right care.
Specialists called hematologists “blood doctors” lead a team of experts to provide the care you need. At the Penn Blood Disorders Center, we bring together a specialized group focused on benign blood disorders. We also work closely with the Abramson Cancer Center at Penn Medicine to treat some conditions, such as blood cancers (hematological malignancies).
Hematology and blood health
People travel to see us from across the Mid-Atlantic and beyond. While we offer the top care they seek, they tell us they also appreciate the environment we’ve created. We know blood disorders can feel challenging at times, so we’ve created a place where you can feel comfortable and supported.
What you can expect when you choose our center
- Welcoming expertise: Our doctors are leaders in the field of blood disorders. They publish influential papers, give talks worldwide, and serve in professional groups, such as the American Society of Hematology. They know, though, that the best care goes beyond expertise. They want your experience to feel comfortable, like a visit to your local doctor’s office.
- Thorough care: We have one of the largest, most complete hematology groups in the region. In addition to hematologists, our team includes nurses and other advanced practice providers, physical therapists, social workers, and a psychologist specializing in pain. A nurse coordinator serves as your main contact. We also partner with a range of other top Penn Medicine specialists.
- Flexibility: You can choose to get all your care at our center, seek a second opinion, or travel to us only for major checkups. We work with your local doctors to ensure you can receive day-to-day care closer to home if preferred.
- Innovation: We’re working to answer big questions about blood disorders and improve care. In addition to leading research, we participate in clinical trials to develop new treatments, including gene therapy.
Blood disorder specialties
Blood conditions we treat
- Bone marrow failure syndromes
- Hemochromatosis (Iron Overload)
- Hemophilia A
- Hemophilia B (Christmas Disease)
- Idiopathic thrombocytopenic purpura (ITP)
- Myeloproliferative disease
Our doctors
Our providers work with you to plan and deliver exceptional treatment and personalized care.
Locations
Our hospitals, multispecialty medical centers, pharmacies, labs and more offer outstanding, personalized care for patients all across the region.
Related articles
10-year remissions with CAR T therapy in B-cell lymphoma
Many patients with large B-cell lymphoma or follicular lymphoma were still living without a relapse, 10 years after receiving CAR T therapy.
CRISPR-based platform pinpoints drivers of leukemia in patient cells
A new toolkit allows researchers to test potential cancer targets directly in patient-leukemia cells.
Improving treatment for an autoimmune bleeding condition
More than half of patients who received an experimental treatment for immune thrombocytopenia maintained safe platelet counts without bleeding episodes for at least one year.
Patient stories
A five-time survivor who keeps fighting follicular lymphoma
“I have been truly thankful for the medical expertise and personal care I have and continue to receive at Penn Medicine while managing this cancer that continues throughout my life,” said Sharon Dunkel.
Competitive weightlifter takes on rare blood cancer
“I knew the downside—cancer winning this battle,” said Howard Aaron. “But for any competition I’ve competed in, I’ve adapted a method of mental, emotional, and psychological preparation to handle it. I took on this cancer as if it was another competition.”
First-ever CAR T cell patient who lived beyond hope
“I’m looking for [extending life by] a day, a week, or a month, and here they are telling me I don't have cancer,” said Bill Ludwig, years later. “It was just like someone told you, ‘You won the lottery.’”
Stronger than fear
“I remember what another cancer survivor told me after my diagnosis: You’re stronger than you think,” Becky Yu said. “It stuck with me and gave me confidence to believe in myself. The fear of ‘is it coming back?’ is still there at the back of my head, but I keep moving forward.”
A CAR T cell research participant gains unexpected life
“I’ve been so blessed to be in the study,” said Walter Styer, “and to enjoy 68 years of marriage with Sarah.” In the 11 years after he enrolled in an early trial of CAR T cell therapy, they’ve celebrated the weddings of grandchildren, attended graduations, and welcomed 11 great-grandchildren.
A medical mystery solved through pickleball
One morning, Ronnie Recchia woke to discover his right foot had “dropped” and he couldn’t flex it toward his leg. His doctors first assured him his foot function would return. Instead, his condition worsened. But a friendship forged on the pickleball court soon led him to Penn neurologists who could help.
After gene therapy, a lifetime of worries eased
Curt Krouse spent a lifetime worrying about injury because his hemophilia meant his blood might not clot. Then he received a new gene therapy at Penn. “It is hard to explain the feeling. I bang my arm or scratch my leg and instead of infusing, I just watch the affected area clot normally,” Krouse said. “It’s like a science fiction movie, but it’s real.”
How future cures begin as ideas in laboratories
The successes of CAR T research show the importance of the cycle of science—sparking new ideas and clinical trials that give patients better options.